http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H02129224-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_692dc75829481c48c017b52f352e2bad
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G69-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-00
filingDate 1988-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4976ee0fd50cca165cdcb726f7744e30
publicationDate 1990-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H02129224-A
titleOfInvention Preparation of fibrin
abstract PURPOSE: To obtain a fibrin derived from a patient in a short time and under an almost aseptic condition by treating plasma with an enzyme having a thrombin action and polymerizing and solidifying fibrinogen in the plasma. n CONSTITUTION: Fibrin is prepd. by treating plasma obtd. by passing a collected blood through a plasma separating membrane and the obtd. plasma with thrombin or an enzyme having a thrombin-like action such as reptilase, thereby polymerizing and solidifying fibrinogen in the plasma. In this process, it is pref. to add a substance which inhibits fibrin degradation such as Ca 2+ , FXIII, aprotinin tranexamate. Polymn. using this enzyme is pref. performed in a buffer soln. close to neutrality. n COPYRIGHT: (C)1990,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9701728-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9719063-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9950035-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9757721-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10143725-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10400017-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5962026-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11725031-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0485210-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5763410-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5763411-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5739288-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10576130-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8992862-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5804428-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10393728-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9239276-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5770194-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5750657-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10208095-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8801586-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9895418-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H09509432-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9713810-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9533090-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10183042-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9642956-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9897589-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9649579-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10441634-B2
priorityDate 1988-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP84122
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422600743
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415966231
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID373926
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16130295
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439199
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81070
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22775
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90470996
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431577138

Total number of triples: 54.